Gennova Biopharmaceuticals News and Activities

Gennova Biopharmaceuticals is owned by Emcure.

Emcure is one of the...

• Nifty 500;
• TOB Iconic 10,000.

Emcure is a company listed under the stock ticker EMCURE (IN).

Emcure has a direct presence in 2 countries.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 23 main executives

Most searched biographies at Gennova Biopharmaceuticals

• Sanjay Singh, Chief Executive Officer
• Kavita Singh, Independent Director
• Shailesh Ayyangar, Chairman and Independent Director

Popular executive movements at Emcure

• Jatin Nayyar has joined the company as Executive Vice President  (posted on June 1 2026).
• Amarendra Kumar has joined the company as Senior Vice President  (posted on March 19 2026).
• Namita Thapar, Whole-time Director, has left the company  (posted on March 11 2026).

Click here to view some more movements at Emcure

Create your alert
to follow the executive moves at Gennova Biopharmaceuticals.

Emcure has 2,403 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Gennova Biopharmaceuticals

Social media about Gennova Biopharmaceuticals

• Gennova Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Gennova Biopharmaceuticals on LinkedIn, X (Twitter) & YouTube